Back to News
Market Impact: 0.4
Glaukos Swings To Profit In Q3, Lifts Full-Year 2026 Guidance; Shares Surge Pre-Market
Source: Nasdaq
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsHealthcare & Biotech
Glaukos reported 58% revenue growth in Q3 2026, returned to profitability, and raised its full-year 2026 revenue guidance. The results indicate improved performance and a stronger outlook, though the article provides no absolute revenue or profit figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
GKOS0.85
More News
- Stocks making the biggest moves midday: ADT, Alphabet, Caterpillar, Eli Lilly, Chipotle & more
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Norwegian shares surge 13% on earnings beat, guidance raise
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- Taiwan Stocks Heads for Correction as Global AI Selloff Deepens